Cervical Cancer Treatment Market : Global Industry Trends, Market Size, Leading Players and Forecast 2018-2026|Credence Research

The global cervical cancer treatment market is expected to expand at a CAGR of 5.2% from 2018 to 2026.

SANJOSE, United States - January 15, 2019 /MarketersMedia/ —

The latest market report published by Credence Research, Inc. “Global Cervical Cancer Treatment Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global cervical cancer treatment market is expected to expand at a CAGR of 5.2% from 2018 to 2026.

Market Insights

According to the latest research citings of World Health Organization (WHO) in 2018, approximately 570,000 new cases if cervical cancer were reported which eventually represents 6.6% of all female cancers. The early manifestation of cervical cancer are vaginal bleeding after sexual intercourse with excruciating pain. The 2 main types of cervical cancer are squamous cell carcinoma and adenocarcinoma. Early diagnosis and vaccination with Gardasil can prevent the advent of cervical cancer. In the last decade there has been a paradigm shift in the treatment regimen from chemotherapy to targeted therapy. Biologics in the phase III clinical trials such as nimotuzumab and atezolizumab will provide a positive thrust to the cervical cancer treatment market growth.

Browse the full report Cervical Cancer Treatment Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/cervical-cancer-treatment-market

Chemotherapy is reigning the product segment for cervical cancer treatment market. Placitaxel, cisplatin, carboplatin, gemcitabine are given either alone or in combination with radiation therapy for patients suffering with advanced stage cervical cancer. The combination therapy is helpful but causes severe adverse effects. Cervical hysterectomy is helpful in women suffering with early stage cervical cancer. Targeted drug therapy will be the fastest growing market on account of its excellent clinical outcomes, dose tolerability and patient compliance.

North America presently maintains supremacy in the regional segment for cervical cancer treatment market. According to Center for Disease Control And Prevention (CDC), cervical cancer is the second most common type of cancer in women after breast cancer resulting in mortality due to lack of early screening and medical intervention. Rising public health awareness and affordable reimbursement scenario drive the cervical cancer treatment market growth in North America. In Europe cervical cancer is responsible for the mortality of 70% patient actively diagnosed with cervical cancer. Presence of key players such as F.Hoffman La-Roche AG., Merck & Co., Inc., and GlaxoSmithkline, Plc. etc. propel the cervical cancer treatment market growth in the European Region. Asia Pacific will be the fastest growing market during the forecast period owing to the presence of huge generic market and proactive government policies to fight cervical cancer.

Biopharmaceutical companies having a strong foothold in the cervical cancer treatment market are, Allergan, Plc., Biocon Ltd., CooperSurgical, Inc., Eli Lilly & Company, F.Hoffman La-Roche AG, GlaxoSmithkline Plc., Ethicon, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd. and Varian Medical Systems, Inc.

Get Sample with more graphs and details for better understanding: https://www.credenceresearch.com/sample-request/59521

Key Market Movements:

Increasing cases of women being diagnosed for cervical cancer throughout the globe
Rising public health awareness and affordable reimbursement scenario for the generic drugs employed for the treatment of cervical cancer
Vaccination such as Gardasil is helpful in prevention of HPV infection and strong biologics pipeline with drugs in phase III clinical trials such as nimotuzumab and atezolizumab

ToC:
Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Cervical Cancer Treatment Market Portraiture
2.2. Global Cervical Cancer Treatment Market, by Product, 2017 (US$ Mn)
2.3. Global Cervical Cancer Treatment Market, by Geography, 2017 (US$ Mn)

Chapter 3. Cervical Cancer Treatment Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Cervical Cancer Treatment Market, by Key Players, 2017

Chapter 4. Global Cervical Cancer Treatment Market, by Product
4.1. Overview
4.2. Chemotherapy
4.3. Targeted Therapy
4.4. Surgical Procedure
4.5. Radiation Therapy
4.6. Others
4.7. Pipeline Analysis
4.7.1. Phase III Drugs
4.7.1.1. Z-100
4.7.1.2. ADXS11-001
4.7.1.3. Nimotuzumab
4.7.1.4. Atezolizumab
4.7.2. Tabular Representation of Drug Pipeline in Phase II and I

Browse the full report Cervical Cancer Treatment Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/cervical-cancer-treatment-market

Related Report:

Cervical Cancer Diagnostic Test Market: https://www.credenceresearch.com/report/cervical-cancer-diagnostic-test-market

Breast Cancer Treatment Market: https://www.credenceresearch.com/report/breast-cancer-treatment-market

Prostate Cancer Treatment Market: https://www.credenceresearch.com/report/prostate-cancer-treatment-market

Patient Monitoring Devices Market: https://www.credenceresearch.com/report/patient-monitoring-devices-market

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals. Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa. Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com/report/cervical-cancer-treatment-market

Source URL: https://marketersmedia.com/cervical-cancer-treatment-market-global-industry-trends-market-size-leading-players-and-forecast-2018-2026credence-research/470569

Source: MarketersMedia

Release ID: 470569